Abcam vs Alithea Genomics

Abcam vs Alithea Genomics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Abcam is on 61/100 and Alithea Genomics on 50/100.

Abcam logo
AbcamGlobal supplier of life science research tools, including antibodies, reagents, and assays.
Try Abcam
Alithea GenomicsUnlocking industrial-scale RNA-seq for primary drug screening and toxicology.
Try Alithea Genomics

Where each one leads

Abcam

  • our overall score: 61/100 against 50/100
  • funding raised: $257M against $11.1M

Alithea Genomics

Leads on none of the measures we hold for both companies.

At a glance

MeasureAbcamAlithea Genomics
What it isGlobal supplier of life science research tools, including antibodies, reagents, and assays.Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.
CategoryBiotechnology, Life Sciences, Discovery Tools, AntibodiesBiotechnology, Drug Discovery, Genomics, Life Sciences
Sells toBusiness modelB2BB2B
OfferingSoftware | hardware | services | marketplace | platformPlatform
Founded19982021
HeadquartersCambridge, United KingdomZurich, Switzerland
StatusActiveInactive

Size, funding and growth

MeasureAbcamAlithea Genomics
Total funding$257M$11.1M
Latest roundSeries DSeed

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAbcamAlithea Genomics
StartupHub scoreOur 0-100 rating61/10050/100
Traction40/10035/100
Team70/10070/100
Community15/10015/100
Search visibility16/10021/100
Quality78/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (22/100)F (22/100)
Domain ratingLink authority, 0-10072/100Not published

Abcam vs Alithea Genomics: common questions

Which is better, Abcam or Alithea Genomics?

On our 0-100 score Abcam rates higher (61/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Abcam and Alithea Genomics compare on the numbers?

Abcam leads on our overall score (61/100 against 50/100), funding raised ($257M against $11.1M).

Read the full Abcam review and pricing or the Alithea Genomics review and pricing. You can also browse other Abcam alternatives we track.